Phenylacetyl chloride → N-[6-Chloro-2,4,8,22-tetraazatetracyclo[14.3.1.1(3,7).1(9,13)]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaen-12-yl]-1-(phenylacetyl)piperidine-4-carboxamide Trifluoroacetate
Reaction equation
[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].FC(F)(F)C(O)=O.[Cl:15][C:16]1[CH:17]=[N:18][C:19]2[NH:20][C:21]3[CH:22]=[CH:23][CH:24]=[C:25]([CH:46]=3)[CH2:26][CH2:27][C:28]3[CH:36]=[C:32]([NH:33][C:34]=1[N:35]=2)[CH:31]=[CH:30][C:29]=3[NH:37][C:38]([CH:40]1[CH2:45][CH2:44][NH:43][CH2:42][CH2:41]1)=[O:39].[C:47]1([CH2:53][C:54](Cl)=[O:55])[CH:52]=[CH:51][CH:50]=[CH:49][CH:48]=1>>[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[Cl:15][C:16]1[CH:17]=[N:18][C:19]2[NH:20][C:21]3[CH:22]=[CH:23][CH:24]=[C:25]([CH:46]=3)[CH2:26][CH2:27][C:28]3[CH:36]=[C:32]([NH:33][C:34]=1[N:35]=2)[CH:31]=[CH:30][C:29]=3[NH:37][C:38]([CH:40]1[CH2:45][CH2:44][N:43]([C:54](=[O:55])[CH2:53][C:47]2[CH:52]=[CH:51][CH:50]=[CH:49][CH:48]=2)[CH2:42][CH2:41]1)=[O:39]Participants
3
Reactant 2
Product 1
Procedure
The desired compound was prepared according to the procedure of Example A20, using N-[6-chloro-2,4,8,22-tetraazatetracyclo[14.3.1.1(3,7).1(9,13)]docosa-1(20), 3(22),4,6,9(21),10,12,16,18-nonaen-12-yl]piperidine-4-carboxamide bis(trifluoroacetate) and benzeneacetyl chloride as starting materials in 70% yield. 1H NMR (300 MHz, DMSO-d6): δ 9.61 (s, 1H), 9.44 (s, 1H), 9.32 (s, 1H), 8.18 (s, 1H), 7.97 (s, 1H), 7.72 (s, 1H), 7.20 (m, 7H), 7.03 (m, 2H), 6.89 (d, 1H), 6.79 (d, 1H), 4.42 (d, 1H), 4.01 (d, 1H), 3.73 (s, 2H), 3.02 (m, 1H), 2.81 (m, 4H), 2.63 (m, 2H), 1.80 (m, 2H), 1.41 (m, 2H). LCMS for C32H32ClN6O2(M+H)+: m/z=567.2.
Sources & evidence
- ORD record
- ord-72d82ad4dff24fd8b0b579a9e3daec0d
- Source dataset
- uspto-grants-2014_10
- Patent number
- US08871753B2
Reaction notes
Loading…